The war on cancer

[1]  P. Price,et al.  Important advances in oncology 1996 , 1997 .

[2]  F. Mitelman,et al.  Catalog of Chromosome Aberrations in Cancer , 1996, British Journal of Cancer.

[3]  J. Karp,et al.  The secondary leukemias: challenges and research directions. , 1996, Journal of the National Cancer Institute.

[4]  C. la Vecchia,et al.  Worldwide trends in cancer mortality in the elderly, 1955-1992. , 1996, European journal of cancer.

[5]  V. Beral,et al.  Breast cancer mortality rates are levelling off or beginning to decline in many western countries: analysis of time trends, age-cohort and age-period models of breast cancer mortality in 20 countries. , 1996, British Journal of Cancer.

[6]  L. Robison,et al.  Breast cancer and other second neoplasms after childhood Hodgkin's disease. , 1996, The New England journal of medicine.

[7]  F. Collins.  BRCA1--lots of mutations, lots of dilemmas. , 1996, The New England journal of medicine.

[8]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[9]  T. Pedersen.  Lowering cholesterol with drugs and diet. , 1995, The New England journal of medicine.

[10]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[11]  J. Folkman,et al.  A strategy to discover circulating angiogenesis inhibitors generated by human tumors. , 1995, Cancer research.

[12]  E. Farber,et al.  Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. , 1995, Cancer research.

[13]  F. Li.  The 4th American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention. Phenotypes, Genotypes, and Interventions for Hereditary Cancers. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  R. Lotan,et al.  Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  Koop Ce,et al.  A personal role in health care reform. , 1995 .

[16]  V. Jordan,et al.  Endometrial carcinoma and tamoxifen: clearing up a controversy. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  J. Fraumeni,et al.  Recent Cancer Trends in the United States , 1995 .

[18]  B. Brenner,et al.  Hypertension: Pathophysiology, Diagnosis, and Management , 1994 .

[19]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[20]  J. Rowley,et al.  The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. , 1994, Blood.

[21]  L. Wattenberg.  Prevention--therapy--basic science and the resolution of the cancer problem. , 1993, Cancer research.

[22]  V. Steele,et al.  Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy. , 1992, Cancer research.

[23]  Mike Clarke,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women , 1992 .

[24]  M. Sporn,et al.  Carcinogenesis and cancer: different perspectives on the same disease. , 1991, Cancer research.

[25]  E Farber,et al.  Cellular adaptation in the origin and development of cancer. , 1991, Cancer research.

[26]  Anita B. Roberts,et al.  Peptide Growth Factors and Their Receptors I , 1990, Springer Study Edition.

[27]  Zhen-yi Wang,et al.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.

[28]  J. Bailar,et al.  Progress against cancer? , 1986, The New England journal of medicine.

[29]  M. Sporn,et al.  Role of retinoids in differentiation and carcinogenesis. , 1983, Cancer research.

[30]  M. Sporn.  Combination chemoprevention of cancer , 1980, Nature.

[31]  S. Collins,et al.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Bittles.  Incest re-assessed , 1979, Nature.

[33]  L. Sachs.  Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia , 1978, Nature.

[34]  I. Fidler,et al.  Metastasis results from preexisting variant cells within a malignant tumor. , 1977, Science.

[35]  W. Scher,et al.  Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Henderson Ic,et al.  High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out. , 1995 .

[37]  A. Knudson,et al.  Mutation and cancer: a personal odyssey. , 1995, Advances in cancer research.

[38]  W. Clark,et al.  The nature of cancer: morphogenesis and progressive (self)-disorganization in neoplastic development and progression. , 1995, Acta oncologica.

[39]  R. Weinberg.  Prospects for cancer genetics. , 1995, Cancer surveys.

[40]  K. Kinzler,et al.  Colorectal cancer and the intersection between basic and clinical research. , 1994, Cold Spring Harbor symposia on quantitative biology.

[41]  V. Sacchini,et al.  Retinoids and tamoxifen in breast cancer chemoprevention , 1993, International journal of clinical & laboratory research.

[42]  G. Poste,et al.  On the genesis and regulation of cellular heterogeneity in malignant tumors. , 1982, Invasion & metastasis.

[43]  B. Mintz,et al.  Teratocarcinomas and other neoplasms as developmental defects in gene expression. , 1981, Advances in cancer research.

[44]  L. Fink,et al.  Cancer : a problem of developmental biology , 1978 .